- Home
- PRPL vs CRDL Comparison
PRPL vs CRDL Comparison
Compare PRPL & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPL
- CRDL
- Stock Information
- Founded
- PRPL 2010
- CRDL 2017
- Country
- PRPL United States
- CRDL Canada
- Employees
- PRPL N/A
- CRDL N/A
- Industry
- PRPL Home Furnishings
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRPL Consumer Discretionary
- CRDL Health Care
- Exchange
- PRPL Nasdaq
- CRDL Nasdaq
- Market Cap
- PRPL 125.6M
- CRDL 126.5M
- IPO Year
- PRPL N/A
- CRDL N/A
- Fundamental
- Price
- PRPL $1.09
- CRDL $1.05
- Analyst Decision
- PRPL Hold
- CRDL Strong Buy
- Analyst Count
- PRPL 1
- CRDL 2
- Target Price
- PRPL $1.00
- CRDL $9.00
- AVG Volume (30 Days)
- PRPL 776.1K
- CRDL 1.2M
- Earning Date
- PRPL 11-03-2025
- CRDL 08-14-2025
- Dividend Yield
- PRPL N/A
- CRDL N/A
- EPS Growth
- PRPL N/A
- CRDL N/A
- EPS
- PRPL N/A
- CRDL N/A
- Revenue
- PRPL $456,844,000.00
- CRDL N/A
- Revenue This Year
- PRPL N/A
- CRDL N/A
- Revenue Next Year
- PRPL $11.87
- CRDL N/A
- P/E Ratio
- PRPL N/A
- CRDL N/A
- Revenue Growth
- PRPL N/A
- CRDL N/A
- 52 Week Low
- PRPL $0.56
- CRDL $0.77
- 52 Week High
- PRPL $1.29
- CRDL $2.63
- Technical
- Relative Strength Index (RSI)
- PRPL 55.28
- CRDL 39.49
- Support Level
- PRPL $1.05
- CRDL $1.12
- Resistance Level
- PRPL $1.15
- CRDL $1.14
- Average True Range (ATR)
- PRPL 0.09
- CRDL 0.07
- MACD
- PRPL -0.01
- CRDL -0.00
- Stochastic Oscillator
- PRPL 39.29
- CRDL 5.56
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.